free web stats
Category

Archived Press Releases

Variation Biotechnologies Secures $35.7M in Series A Financing to Fund Innovative Vaccine Platform

By | Archived Press Releases

Variation Biotechnologies Inc. (VBI), a privately held biopharmaceutical company focused on the development of vaccines for infectious diseases using a novel platform technology, announced today it has secured US$35.7 million in Series A financing. VBI will use the proceeds to advance the company’s innovative Variosite™ vaccine platform into clinical development,…

Read More